drugset / Trial / NCT00552305

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

NCT00552305

Phase 2 Completed 370 enrolled UCB Pharma
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy.

Timeline

Start
2001-08
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacosamide Other / unclassified 800 mg Oral

Indications